LAUSANNE, Switzerland and AALEN, Germany—Creal, a display technology startup, has announced a license agreement with Zeiss, a leading manufacturer of eyeglass lenses and ophthalmic instruments, with the goal to create a digitized vision care platform to improve current vision diagnostic and treatment procedures. By leveraging Creal's light field display technology, Zeiss advised, it plans to bring to market devices that allow for the digital examination of eye conditions as well as virtual simulation of classic ophthalmic lenses, contact lenses, and more.

Through the integration of Creal's light field display into vision test devices, Zeiss said it expects to introduce a solution allowing for precise digital diagnosis of eye defects. By replicating real-world light to provide digital imagery with genuine depth, Creal's true 3D display will enable the digital replication of any physical or theoretical lens, allow test procedures to be tailored to any age group/customer segment, as well as enable the projection of automated content, limiting the need for clinical resources overall, the company stated.

"As the pioneer of scientific optics, Zeiss' mission has always been to challenge the limits of human imagination," said Antia Alonso, PhD, vice president of Zeiss Vision Technology Solutions. "We see our collaboration with Creal and the consequent development and rollout of our digitized vision care platform as a way to revolutionize the prescription eyewear customer buying experience, elements of which still rely on antiquated technology, developed over a century ago."